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Summary Tumorigenic mouse lung-derived type 2 cell lines have large reductions in both ,B-adrenergic-
stimulated cAMP production and ligand binding to ,B-adrenergic receptors. These tumorigenic cells are also
relatively insensitive to glucocorticoids. Because glucocorticoids regulate both ,B-adrenergic receptor expression
and receptor coupling to the stimulatory guanine nucleotide binding protein G., interactions between the
glucocorticoid and P-adrenergic signalling systems were examined. This study demonstrates that ,B-adrenergic
ligand binding and agonist sensitivity are increased in a tumorigenic cell line stably expressing a normal
glucocorticoid receptor transgene. However, although the transfected tumour cells and non-tumorigenic cells
have similar amounts and affinities of ,B-adrenergic agonist and antagonist binding, similar amounts of G,
subunits and similar forskolin-stimulated adenylyl cyclase activities, the former remain much less isoproterenol
responsive. Competition binding studies demonstrate that tumour cell ,B-adrenergic receptors have both high-
and low-affinity agonist binding but are functionally uncoupled from G,. This uncoupling may involve an
alteration in G,, as guanine nucleotides exhibit a reduced ability to stimulate adenylyl cyclase. Thus, some
aspects of tumorigenic cell dysfunction in ,B-adrenergic signalling can be ameliorated by interactions with the
glucocorticoid pathway, but additional defects are also involved.
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,B-Adrenergic receptor (PAR) expression and P-adrenergic
hormone sensitivity increase during lung development and
glucocorticoids accelerate these increases (Cheng et al., 1980;
Barnes et al., 1984). In some cell types, glucocorticoids
increase PAR expression (Collins et al., 1988) or PAR
coupling to G. (Davies and Lefkowitz, 1984), the hetero-
trimeric guanine nucleotide-binding protein that regulates
PAR stimulation of adenylyl cyclase (Levitzki, 1988). When
compared with two non-tumorigenic mouse lung alveolar
type 2-derived cell lines, a number of tumorigenic cell lines of
type 2 cell origin exhibit aberrant signal transduction
including considerable reductions in sensitivity to both f,-
adrenergic (Droms et al., 1989; Lange-Carter et al., 1992) and
glucocorticoid (Droms et al., 1993) hormones. As both f,-
adrenergic and glucocorticoid signals are major regulators of
type 2 cell function (Ballard, 1986), the defects in these
systems may be important aspects of the neoplastic
progression of type 2 cells.
The heterotrimeric G protein G, consists of a, ,B and y
subunits. Hormone binding to receptor induces G,a to
exchange bound GDP for GTP, resulting in adenylyl cyclase
activation. Hydrolysis of the terminal phosphate restores the
resting state (Levitzki, 1988). The PAR exhibits two affinity
states for agonist binding: one of higher relative affinity (kH)
and the other of low affinity (kL) and glucocorticoids can
affect both the relative proportions and affinities of these two
sites (Davies and Lefkowitz, 1981). The proposed molecular
basis of the high-affinity binding site is that agonist binding
to receptor results in formation of a 'ternary complex'
consisting of hormone, receptor and G protein (De Lean et
al., 1980). Thus, the existence of high-affinity agonist binding
sites is an indicator of the 'coupling' between receptor and G
protein. Addition of guanine nucleotides destabilises this
ternary complex, resulting in low-affinity hormone binding
(Rodbell et al., 1971). The relative ability of guanine
nucleotides to induce the low-affinity state is an indicator
of functional coupling between receptor and G-protein
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(Cheung et al., 1989). It is not clear whether glucocorticoid
enhancement of PAR-G. coupling involves glucocorticoid
effects on the PAR or G. or what the mechanisms of these
effects might be. However, glucocorticoid treatment of
cultured fibroblasts increased GTP-dependent activation of
adenylyl cyclase in the absence of added hormone (Johnson
and Jaworski, 1983), suggesting that some glucocorticoid
effects can be exerted distal to hormone receptors.
Tumour-associated decreases in receptor-coupled adenylyl
cyclase activity often result from reduced receptor affinity or
number (Hunt and Martin, 1980). Indeed, the lack of
sensitivity of mouse lung tumour cells to P-adrenergic
agonists does involve decreased numbers of PAR (Lange-
Carter et al., 1992). In addition, these tumour cells exhibited
altered guanine nucleotide analogue binding to a 45 kDa
membrane associated protein and enhanced cholera toxin
responsiveness (Droms et al., 1989; Lange-Carter et al.,
1992), suggesting the hypothesis that G-protein function
might be altered in mouse lung tumours. As glucocorticoids
enhance both PAR expression and PAR-G. coupling (Davies
and Lefkowitz, 1984), both defects in the ,B-adrenergic
signalling pathway could result from the loss of glucocorti-
coid responsiveness. Glucocorticoids may exert independent
effects on the PAR and G. or, as even unoccupied PAR can
influence G protein activity (Bond et al., 1995), the functional
alteration in tumour cell G. may result directly from
decreased PAR expression. Alternatively, the reduced GTP-
dependent coupling of receptors to adenylyl cyclase activa-
tion observed in hepatomas (Okamura and Terayama, 1976),
suggests that independent defects in G. may also occur in
tumours.
This study addresses the mechanisms of defective ,B-
adrenergic signal transduction in tumorigenic mouse alveolar
type 2 cell lines and uncovers both glucocorticoid-dependent
and independent mechanisms. Reduced ,BAR expression can
be ameliorated by dexamethasone treatment of a tumorigenic
cell line stably expressing a transfected glucocorticoid
receptor gene. In response to dexamethasone, this trans-
fected cell line exhibits the same number and affinities of
PAR antagonist and agonist binding sites as non-tumorigenic
cells. However, even though these tumour cells exhibit
dexamethasone enhancement of isoproterenol-stimulatedNeoplastic type 2 cell signalling defects
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intracellular cAMP production, they remain much less
isoproterenol responsive than non-tumorigenic cells. This
relative insensitivity results from a loss of functional ,BAR-
Gs coupling that may involve an intrinsic defect in the
interaction of G, with guanine nucleotides.
Materials and methods
Cell lines
The non-tumorigenic (C10) and tumorigenic (A5) type 2 cell
lines were derived and cultured as described previously
(Bentel et al., 1989; Droms et al., 1989, 1993). A5 cells were
transfected by addition of media conditioned by VDG12P2
cells (supplied by Dr Gary Firestone, University of
California, Berkeley, CA, USA). VDG12P2 cells release
recombinant virus with the rat glucocorticoid receptor gene
linked to neomycin resistance (Cook et al., 1988). After
selection in 600 ,ug ml-1 geneticin (G418, Gibco, Grand
Island, NY, USA), a single resistant colony remained. Cells
from this colony were isolated and named A5GR1. A5GR1
cells express the transfected glucocorticoid receptor (Droms,
1995) and are routinely cultured with 200 Mg ml-' geneticin
to maintain this expression. For all experiments, cells were
plated on Corning tissue culture dishes in CMRL 1066
medium with 5% fetal bovine serum (FBS), 100 units ml-'
penicillin, and 100 Mg ml-' streptomycin and allowed to
attach overnight. On the following day cells were rinsed twice
with 0.9% sodium chloride, and media containing 4% FBS
from which endogenous steroids were removed with charcoal
was added. At this time, 10 nM dexamethasone was added to
the samples indicated in Results. Cells were cultured for an
additional 4 days before experimental analyses.
Receptor binding studies
Cells were plated at a density of 1.3 x 10 - 5 x105 cells per
100 mm culture dish. Membranes were prepared as described
previously (Lange-Carter et al., 1992) and stored for up to 9
days at -80°C before use. For saturation binding studies 5-
10 Mg of membrane protein per sample was incubated for
90 min at 37°C with (-)'25I-labelled cyanopindolol (125ICYP,
2200 Ci mmol-1; DuPont NEN, Boston, MA, USA) ranging
in concentration between 10 and 200 pM as described
previously (Lange-Carter et al., 1992). Protein concentration
was determined by the Lowry method (Lowry et al., 1951).
For isoproterenol competition studies, membranes were
incubated with 30 pM 125ICYP and isoproterenol ranging in
concentrations between 1 nm and 1 mM as described
previously (Valverius et al., 1987). In some cases, GTP was
included at the concentrations indicated. Membranes were
harvested on glass fibre filters (Whatman GF/C) and counted
in a gamma counter. Non-specific binding ranged between
27% and 32% for all conditions and was determined by
adding 1 jiM of the unlabelled antagonist propranolol. Non-
specific binding has been subtracted from all data presented.
Competition binding data were analysed with the Ligand
program (Munson and Rodbard, 1983).
cAMP radioimmunoassay
CIO cells were plated at a density of 5 x 104 cells per 60 mm
culture dish and A5 and A5GR1 cells at 105 cells per 60 mm
dish. Cell lysates were harvested in 10% trichloroacetic acid
(TCA) after 1 min treatment with 1 guM isoproterenol in
buffer (130 mM sodium chloride, 5 mM potassium chloride,
1 mm calcium chloride, 1 mm magnesium sulphate, 1 mM
potassium hydrogen phosphate, 6 mM glucose, 1 mM ascorbic
acid, 25 mM Hepes, pH 7.4) at 37°C. After three extractions
with diethyl ether, the TCA-soluble fraction was assayed for
cAMP using a radioimmunoassay kit (Amersham, Arlington
Heights, IL, USA). The TCA-insoluble fraction was
solubilised with 0.2 N sodium hydroxide and assayed for
protein by the Lowry method (Lowry et al., 1951).
Adenylyl cyclase assays
Cell membranes (5-10,ug membrane protein per sample)
were incubated for 20 min at 30°C with 0.1 mm unlabelled
ATP, 1 uCi per sample of [x-32P]ATP (30 Ci mmol ';
DuPont NEN, Boston, MA, USA), 1 mM f,-mercaptoetha-
nol, 5 mM magnesium acetate, 50 jM cAMP (to competitively
saturate phosphodiesterase), 10 mM creatine phosphate and
10 units ml-1 creatine phosphokinase. [32P]cAMP was
separated from [32P]ATP by ion exchange chromatography
as described previously (Salomon, 1979). Some reactions
included isoproterenol, guanine nucleotides or forskolin as
indicated in Results.
Western blots
Equal amounts of membrane protein (40 jig) from dexa-
methasone-treated ClO and A5GR1 cells were separated by
10% sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis (SDS-PAGE) as described previously (Droms et al.,
1989). Resolved proteins were electrophoretically transferred
to BA85 nitrocellulose (Schleicher and Schuell, Keene, NH,
USA) in buffer containing 190 mM glycine, 20% methanol
and 25 mM Tris, pH 8.3. Nitrocellulose membranes were
subsequently incubated for 1.5 h in block buffer, consisting of
5% bovine serum albumin and 0.1% NP-40 in PBS (140 mM
sodium chloride, 4 mM disodium hydrogen phosphate, 3 mM
potassium chloride, 1.5 mM potassium hydrogen phosphate,
0.5 mM calcium chloride, 0.5 mM magnesium chloride,
pH 7.4), rinsed 3 x 10 min in PBS and incubated for 12-
16 h at 4°C with gentle rocking in block buffer with either a
1:16 000 dilution of an anti-G,Lx rabbit polyclonal antibody
(UBI, Lake Placid, NY, USA) or with a 1: 40 000 dilution of
anti-human GA common rabbit polyclonal antiserum (UBI).
After rinsing 3 x 10 min in PBS, membranes were incubated
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Figure 1 Scatchard analysis of 125ICYP binding. Cell membranes
were incubated with a range of 125ICYP concentrations. Specific
binding (total 125ICYP binding minus that in the presence of 1 ,UM
propranolol) was assayed as described in Materials and methods.
A5 and A5GR1 cells cultured without dexamethasone and A5
cells cultured with 10nm dexamethasone had few binding sites,
although the exact number is uncertain as a large percentage of
the total binding is non-specific and the points lie very close to the
origin. In constrast, when A5GR1 cells were cultured with
dexamethasone 125ICYP binding was similar to that observed in
CIO cells. Each point is the mean of duplicate determinations
from a representative assay. 0, CIO; E], A5GRI; A, A5; open
symbols, minus dexamethasone; closed symbols, + 1Onm dex-
amethasone.
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with a 1:4000 dilution of alkaline phosphatase conjugated
goat anti-rabbit secondary antibody (Cappel, Westchester,
PA, USA). Detection was achieved by incubating the blots in
alkaline phosphatase buffer (100 mM sodium chloride, 50 mM
magnesium chloride, 100 mM Tris pH 9.5) containing 400 gM
5-bromo-4-chloro-3-indolyl-phosphate (Sigma, St Louis, MO,
USA) and 400 gM nitro blue tetrazolium (Sigma). The
resultant blots were scanned with a Mirror 1200 scanner
(Mirror Technologies, St Paul, MN, USA) and signals were
quantified using the NIH Image program.
Results
The number and affinity of '25ICYP binding sites are similar in
dexamethasone-treated CIO and A5GRI cells
Some tumorigenic mouse lung-derived cell lines have reduced
PAR expression compared with non-tumorigenic cells
(Lange-Carter et al., 1992). Both the neoplastic A5 cell line
and the stable glucocorticoid receptor-transfectant cell line
A5GR1 also have very few membrane-associated PAR, as
determined by saturation binding of the antagonist 1251CYP
(Figure 1). Culturing the A5 cell line with dexamethasone did
not increase 1251CYP binding (Figure 1). However, when
cultured with 10 nM dexamethasone, the A5GR1 cells
exhibited similar numbers of,AR as CIO cells (Figure 1).
There were no significant differences in kD or Bmax between
CIO cells cultured without dexamethasone, ClO cells with
10 nM dexamethasone or A5GR1 cells with 10 nM dexa-
methasone [kD=23+2.6 (s.e.m.), 35+9.6 and 30+12 pM,
P>0.1; Bmax =88+ 10, 91 + 11, 80+7.7 fmol per mg protein,
P>0.5; n=6, 4 and 5 respectively]. Statistical analyses were
by one-way ANOVA.
Table I Radioimmunoassay of isoproterenol-stimulated cAMP
production
Cell line 10 nM dex Basal 1 ,iM iso
AS 2.3 + 0.28 5.4 + 0.73
+ 2.0+0.37 6.2 +0.47
A5GR1 4.2±0.11 8.0+1.1
+ 2.5+0.35 36+7.3
CIO 11±1.6 280+38
+ 12±4.0 370±23
Intracellular cAMP production after 1 min treatment with 1 uM
isoproterenol (iso) was significantly (P<0.01) enhanced if CIO or
A5GR1 cells were cultured for 4 days with 10 nM dexamethasone
(dex), whereas A5 cell isoproterenol responsiveness was unaffected.
Basal intracellular cAMP was also greater in CIO than in A5 or
A5GR1 cells, but was not affected by dexamethasone treatment.
Numbers represent the mean ±s.e.m. cAMP produced (pmol cAMP
per mg protein). Statistical analyses were by t-tests. n=6 for each
condition.
Table II Basal and isoproterenol-stimulated adenylate cyclase
activity
Cell line Basal 100 nM iso 10 gM iso
A5GR1 130+ 12 480+9.8 530+6.7
CIO 260+46 2700+ 110 2700+ 160
Membranes fromA5GRl cells cultured with 10 nM dexamethasone
have both lower basal and lower isoproterenol (iso)-stimulated
adenylate cyclase activities compared with CIO cells cultured with
dexamethasone. Numbers represent the mean+s.e.m. cAMPproduced
(pmol cAMP per mg protein per 20 min) from two assays (n =6 for
each condition).
Dexamethasone-treated A5GRJ cells are much less
isoproterenol responsive than CIO cells
Intracellular cAMP production stimulation by the ,B-
adrenergic agonist isoproterenol did increase approximately
5-fold when A5GR1 cells were cultured with 10 nM
dexamethasone, whereas no such increase was observed in
A5 cells (Table I). However, although CIO and A5GR1 cells
cultured with dexamethasone had similar number of 125ICYP
binding sites, A5GR1 cells remained much less responsive to
isoproterenol both in whole cells (Table I) and in crude
membrane fractions (Table II). The dexamethasone-induced
increase in ,B-adrenergic responsiveness in A5GR1 cells is
likely to result from the increase in ,BAR expression. The
approximate 30% increase in isoproterenol responsiveness in
CIO cells cultured with dexamethasone compared with
control CIO cells was not associated with increased PAR
expression and involves enhanced coupling of the PAR to Gs
(KA Droms, unpublished). CIO cells also exhibited a greater
basal level ofintracellular cAMP than did A5 or A5GR1 cells
(Table I) and an increased basal adenylyl cyclase activity
compared with A5GR1 cells (Table II). The increased basal
adenylyl cyclase activity in CIO cells may be due to a
difference in the activity of Gs between cell lines (see below).
CJO and A5GR1 cells have similarforskolin-stimulated
adenylyl cyclase activities
As both basal and isoproterenol-stimulated adenylyl cyclase
activities are lower in ASGR1 than in CIO cells, a difference
between cell lines in the activity of adenylyl cyclase is
possible. However, when membranes prepared from CIO and
ASGR1 cells cultured with dexamethasone were stimulated
with 100 gM forskolin, which activates adenylyl cyclase
directly (Downs and Aurbach, 1982), only a slight difference
in adenylyl cyclase activity was observed (Figure 2). This
difference in forskolin-stimulated adenylyl cyclase activity is
much less than the isoproterenol sensitivity difference
between cell lines. In fact, as the basal activity is also lower
in ASGR1 cells, the fold stimulation by forskolin is greater
than in CIO membranes.
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Figure 2 Forskolin-stimulated adenylyl cyclase activity. Mem-
branes from CIO and A5GR1 cells cultured with 10nM
dexamethasone do exhibit a slight difference in forskolin-
stimulated adenylyl cyclase activity, but this difference is much
less than the difference between cell lines in isoproterenol
sensitivity. Basal adenylyl cyclase activity is also lower in
A5GR1 cells. Data from two assays are combined, n=6 for
each condition. 2, Basal activity; *, + 100gM forskolin.
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Figure 3 G,oC and G,B Western blots. CIO (lanes 1) and A5GR1
(lanes 2) cells were cultured with 10nM dexamethasone and
membranes prepared as described in Materials and methods.
Representative blots probed with anti-Gsx or anti-G,B are shown.
No clear difference between cell lines in the amount of these
subunits has been observed. Both the 45 kDa and 52kDa
molecular weight forms of Gsa are observed in CO0 and
A5GR1 cells. For comparison, S49wt type cells, which express
both G,a isoforms, and S49cyc- cells, which do not express G,a
(Harris et al., 1985), are also shown. The blot shown is
representative of at least three blots for each subunit.
CIO and A5GRI cells have similar levels of Goc and Gf
subunit expression
In some cases, the relative levels of expression of G protein
subunits can regulate receptor-G protein coupling (Blumer
and Thorner, 1990). Therefore, G,cC and G3 subunit
expression were examined on Western immunoblots (Figure
3). For each subunit, three individual blots were quantified as
indicated in Materials and methods and the signal from CIO
cells was set to 1 (signals from the 45 kDa and 52 kDa forms
of G,ca were combined). A5GRl cells did not differ
significantly (P>0.5 for both subunits) from CIO for either
G,aO (1.1+0.31 s.e.m.) or Gfl (0.91 +0.33) expression. Thus,
no clear differences between cell lines were observed in the
amounts of any of the components of the ,BAR-coupled
adenylyl cyclase system that might explain their differences in
hormone responsiveness.
The PAR and Gs are functionally uncoupled in A5GRI cells
When A5GR1 and CIO cells are cultured with dexametha-
sone they express similar amounts of,AR and G, and have
similar forskolin-stimulated adenylyl cyclase activities, yet the
A5GRl cells are much less responsive to isoproterenol.
Therefore, the interactions between the components of the
,BAR-coupled adenylyl cyclase system were examined. PAR-
G. coupling was analysed by isoproterenol competition for
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Figure 4 Isoproterenol competition for 125ICYP binding. Both
CIO (a) and A5GR1 (b) cell membranes exhibited low- and high-
affinity isoproterenol binding when incubated without guanine
nucleotide. When 8pM GTP was included, CIO had only low-
affinity isoproterenol binding sites. In constrast, even 40/M GTP
only minimally reduced isoproterenol affinity in A5GR1
membranes. Membranes were prepared from cells cultured with
10nM dexamethasone and incubated with 30pM 125ICYP and the
indicated concentrations of unlabelled isoproterenol. Data were
analysed using the Ligand program (Munson and Rodbard,
1983). Each point is the mean of duplicate determinations from
one assay, whereas each line is the best fit from Ligand analysis of
the combined data from at least three independent assays, except
for A5GR1 -GTP for which two assays were performed (see
Table I). Open symbols, minus GTP; closed symbols, +GTP
(8pM for CIO, 40pM for A5GR1).
Table HI Summary of competition binding data
Cell line [GTP] kH (nM) kL (nM) %RH n
CIO 14+2.6 1500+430 68+4.1 4
8 MM - 510+72 0 3
A5GR1 12+2.0 230+ 20 60+1.5 2
40 MM 30±16 330±70 48±10 3
Membranes from cells cultured with 10 nM dexamethasone were
incubated with 125ICYP, varying isoproterenol concentrations and the
GTP concentrations indicated. The kDs for high (kH) and low (kL)
affinity isoproterenol binding and the percentage ofhigh-affinity sites
(%RH) are reported. Numbers are the mean±s.e.m. of parameters
estimated from Ligand analysis of individual assays. The number of
individual assays for each condition is also reported (n).
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'25ICYP binding in the presence or absence of GTP. In such
assays, fl-adrenergic receptors exhibit two affinity states for
agonist binding: one of higher affinity (kH) and the other of
lower affinity (kL). As demonstrated in Figure 4 and Table
III, both CIO and A5GRl cells exhibit high- and low-affinity
isproterenol binding in the absence of GTP. The presence of
high-affinity sites in both cell lines indicates that there is
fAR-Gs 'coupling' in both cell lines (De Lean et al., 1980).
However, inclusion of GTP in the incubations is much more
effective at reducing high-affinity isoproterenol binding in
CIO than in A5GR1 cells, indicating greater functional
PiAR-Gs coupling in the former (Rodbell et al., 1971;
Cheung et al., 1989). It is also interesting to note that kL is
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Figure 5 Guanine nucleotide stimulation of adenylye cyclase. (a)
GTP produced a concentration-dependent activation of adenylyl
cyclase in membranes prepared from C10 cells that were cultured
with dexamethasone, but was completely ineffective in A5GR1
cells cultured with dexamethasone. (b) The non-hydrolysable
analogue Gpp(NH)p activated adenylyl cyclase in both cell lines,
but to a lesser extent in A5GR1 than in CIO cells. Stimulation of
adenylyl cyclase by Gpp(NH)p in A5GR1 cells that were not
cultured with dexamethasone and, thus expressed very few ,BAR,
was the same as for A5GR1 cells cultured with dexamethasone.
Points represent the combined data from three independent assays
for which triplicate determinations were done, with the exception
of A5GR1 without dexamethasone, for which one assay was
performed. 0, CIO; *, A5GRI; open symbols, minus
dexamethasone; closed symbols, + 10 nM dexamethasone.
much greater in CIO than in A5GR1 cells in the absence of
GTP (Table III). This high kL is typically observed when
flAR-Gs coupling is enhanced by glucocorticoid treatment
(Davies and Lefkowitz, 1981), and is consistent with the
increased isoproterenol responsiveness that was observed in
CIO cells cultured with dexamethasone (Table I). The kL for
CIO cells (140+22 nM) that were not cultured with
dexamethasone is similar to that for A5GR1 cells
(230+20 nM).
Guanine nucleotides stimulate adenylyl cyclase more effectively
in C10 than in A5GRI cells
Neither GTP nor the non-hydrolysable analogue 5-guanylyi-
midio-diphosphate [Gpp(NH)p] activated adenylyl cyclase as
effectively in A5GR1 cell membranes as in ClO membranes
(Figure 5). In fact, GTP at concentrations as high as 100 gM
produced no stimulation of adenylyl cyclase above basal in
A5GR1 cells. Although Gpp(NH)p was also much less
effective in A5GT1 than in ClO cells, 15 gM Gpp(NH)p did
stimulate adenylyl cyclase approximately 3-fold above basal
activity in the former. As adenylyl cyclase was stimulated by
Gpp(NH)p to a similar extent in A5GR1 cells that either
were or were not cultured with dexamethasone (Figure 5), a
defect in Gs that is independent of PAR expression is
implicated.
Discussion
Mouse lung tumour cells have considerably reduced
sensitivity to P-adrenergic stimulation (Droms et al., 1989;
Lange-Carter et al., 1992) and this loss of sensitivity involves
reduced PAR expression (Lange-Carter et al., 1992). The
present work indicates that glucocorticoid treatment of
A5GR1 cells, a tumour cell line stably expressing a
glucocorticoid receptor transgene, does allow restoration of
PAR expression to a level similar to that observed in the
non-tumorigenic ClO cells. The newly expressed PAR is
capable of high-affinity ternary complex formation with
agonist and G, as indicated by the observation that 60% of
isoproterenol binding sites are high affinity (Table III).
Reduced tumour cell ,BAR expression is unlikely to result
directly from loss of glucocorticoid stimulation, as CIO cells
retain a high level of PAR expression even in the absence of
glucocorticoids in the culture medium. Thus, although
glucocorticoid treatment does restore PAR expression in
A5GR1 cells, the cause of reduced expression in tumour
cells is unknown.
Mouse lung tumour cells also exhibited reduced guanine
nucleotide analogue binding to a 45 kDa membrane-
associated protein and enhanced cholera toxin responsive-
ness (Droms et al., 1989; Lange-Carter et al., 1992),
suggesting the hypothesis that G protein function is altered
in the mouse lung tumours. A functional alteration in
tumour cell Gs could result from the reduced PAR
expression rather than from a direct defect in G, itself, as
even unoccupied ,BAR can influence G protein activity
(Bond et al., 1995). However, the present study indicates
that functional flAR-G, coupling is considerably reduced in
A5GR1 cells even when these cells express as many PAR as
CIO cells. This lack of functional PAR-G. coupling in
A5GR1 cells is indicated by a relative inability of GTP to
destablise the high-affinity ternary complex and is associated
with decreased effectiveness of guanine nucleotides to
activate adenylyl cyclase. As A5GR1 cells exhibit a
decrease in non-hydrolysable guanine nucleotide activation
of adenylyl cyclase that is independent of glucocorticoid
treatment and, consequently, ,BAR expression, an indepen-
dent defect in tumour cell Gs is implicated.
One potential mechanism of the reduced ability of guanine
nucleotides to activate G, in tumorigenic mouse lung-derived
cell lines is that guanine nucleotide exchange is reduced
(Droms et al., 1989). The relative inability of GTP to
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destabalise the ternary complex in A5GRl cells is consistent
with this hypothesis. Additionally, the difference between CIO
and A5GR1 cells in the effectiveness of GTP at activating
adenylyl cyclase is even greater than the difference between
cell lines when a non-hydrolysable analogue is used. Thus,
the GTPase activity of Gs may also be enhanced in the
tumour cells. A reduction in the intrinsic guanine nucleotide
exchange rate with an increase in the GTPase activity of Gs
in tumour cells would be predicted to produce a decrease in
basal adenylyl cyclase activity, consistent with the 2- to 3-fold
lower basal intracellular cAMP and adenylyl cyclase activity
observed in A5 and A5GRl cells compared with CIO cells.
Although a clear role for reduced intracellular cAMP in
neoplasia has not been established, agonist-stimulated
adenylyl cyclase activity is reduced in many tumours. One
possibility is that cAMP interferes with mitogenic signal
transduction, as observed in Ratl cells (Cook and
McCormick, 1993) and human small-cell lung cancer cells
(Viallet et al., 1990). Reduced activity of the cAMP-
dependent protein kinase is also a requirement for
mitogenesis in some cells (Lamb et al., 1991). In addition,
cAMP inhibits growth in soft agar of mouse lung tumour
cell lines (KA Droms, unpublished observation). Tumour-
associated reductions in cAMP often result from decreases
in the number or affinity of receptors coupled to adenylyl
cyclase activation (Hunt and Martin, 1980). Alternatively,
defects in the G-proteins that couple receptors to adenylyl
cyclase may also occur. For example, reduced GTP-
dependent coupling of adrenergic receptors to adenylyl
cyclase had been observed in hepatomas (Okamura and
Terayama, 1976). As there are differences between ClO and
A5GRl cells in G, interactions with both the ,BAR (guanine
nucleotide destabilisation of the ternary complex) and
adenylyl cyclase (guanine nucleotide activation of cAMP
production), the structure of one or more of the subunits
of G, may be altered in mouse lung tumour cells. This
possibility is currently being investigated.
Abbreviations
,BAR, ,B-adrenergic receptor; FBS, fetal bovine serum; Gs,
stimulatory heterotrimeric guanine nucleotide binding protein;
Gpp(NH)p, 5'-guanylylimidodiphosphate; 125ICYP, (-)1251-cya-
nopindolol; PBS, phosphate-buffered saline; SDS-PAGE, sodium
dodecyl sulphate polyacrylamide gel eletrophoresis; TCA, tri-
chloroacetic acid.
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